There have been no new topics on the message board since before Christmas. It concerns me that stock was sold to raise funds and the stock was sold recently and not in four or five months after the FDA weighs in. If the company really thinks the FDA will have a positive response and the value of the stock per share would increase, it could have waited and raised the same amount by selling fewer shares and thereby not dilute the existing stock.
OPPPS! I really messed up on my comment and apologize to anyone who read it. I was thinking about ARNA when I wrote it. I will try to do better in the future. Thanks to the respondent who asked what stock I was talking about and thanks to all who comment on the message board.